Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Summary of Non-Vested Options (Detail)

v3.24.1.u1
Stockholders' Equity - Summary of Non-Vested Options (Detail)
3 Months Ended
Feb. 29, 2024
$ / shares
shares
Share-Based Payment Arrangement [Abstract]  
Non-vested at November 30, 2021, Shares | shares 114,193
Granted, Shares | shares 103,000
Vested, Shares | shares (77,783)
Forfeited, Shares | shares 0
Non-vested at February 28, 2022, Shares | shares 139,410
Non-vested at November 30, 2021, Weighted Average Grant-Date Fair Value | $ / shares $ 3.1
Granted, Weighted Average Grant-Date Fair Value | $ / shares 3.13
Vested, Weighted Average Grant-Date Fair Value | $ / shares 3.2
Forfeited, Weighted Average Grant-Date Fair Value | $ / shares 0
Non-vested at February 28, 2022, Weighted Average Grant-Date Fair Value | $ / shares $ 3.07